» Articles » PMID: 33836152

Oncogenic Extrachromosomal DNA Functions As Mobile Enhancers to Globally Amplify Chromosomal Transcription

Abstract

Extrachromosomal, circular DNA (ecDNA) is emerging as a prevalent yet less characterized oncogenic alteration in cancer genomes. We leverage ChIA-PET and ChIA-Drop chromatin interaction assays to characterize genome-wide ecDNA-mediated chromatin contacts that impact transcriptional programs in cancers. ecDNAs in glioblastoma patient-derived neurosphere and prostate cancer cell cultures are marked by widespread intra-ecDNA and genome-wide chromosomal interactions. ecDNA-chromatin contact foci are characterized by broad and high-level H3K27ac signals converging predominantly on chromosomal genes of increased expression levels. Prostate cancer cells harboring synthetic ecDNA circles composed of characterized enhancers result in the genome-wide activation of chromosomal gene transcription. Deciphering the chromosomal targets of ecDNAs at single-molecule resolution reveals an association with actively expressed oncogenes spatially clustered within ecDNA-directed interaction networks. Our results suggest that ecDNA can function as mobile transcriptional enhancers to promote tumor progression and manifest a potential synthetic aneuploidy mechanism of transcription control in cancer.

Citing Articles

MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC.

Fiorini E, Malinova A, Schreyer D, Pasini D, Bevere M, Alessio G Nature. 2025; .

PMID: 40074906 DOI: 10.1038/s41586-025-08721-9.


Three-dimensional regulatory hubs support oncogenic programs in glioblastoma.

Breves S, Di Giammartino D, Nicholson J, Cirigliano S, Mahmood S, Lee U bioRxiv. 2025; .

PMID: 40034649 PMC: 11875237. DOI: 10.1101/2024.12.20.629544.


Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies.

Yang J, Zhou F, Luo X, Fang Y, Wang X, Liu X Cell Death Discov. 2025; 11(1):84.

PMID: 40032852 PMC: 11876437. DOI: 10.1038/s41420-025-02366-3.


BRCA1-A and LIG4 complexes mediate ecDNA biogenesis and cancer drug resistance.

Chung O, Yao S, Yang F, Wang L, Cerda-Smith C, Hutchinson H bioRxiv. 2025; .

PMID: 40027615 PMC: 11870461. DOI: 10.1101/2025.02.18.638901.


Epigenetic priming promotes acquisition of tyrosine kinase inhibitor resistance and oncogene amplification in human lung cancer.

Starble R, Sun E, Gbyli R, Radda J, Lu J, Jensen T bioRxiv. 2025; .

PMID: 39974875 PMC: 11838195. DOI: 10.1101/2025.01.26.634826.


References
1.
Ma K, Qiu L, Mrasek K, Zhang J, Liehr T, Quintana L . Common fragile sites: genomic hotspots of DNA damage and carcinogenesis. Int J Mol Sci. 2012; 13(9):11974-11999. PMC: 3472787. DOI: 10.3390/ijms130911974. View

2.
Dixon J, Xu J, Dileep V, Zhan Y, Song F, Le V . Integrative detection and analysis of structural variation in cancer genomes. Nat Genet. 2018; 50(10):1388-1398. PMC: 6301019. DOI: 10.1038/s41588-018-0195-8. View

3.
Kim D, Paggi J, Park C, Bennett C, Salzberg S . Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019; 37(8):907-915. PMC: 7605509. DOI: 10.1038/s41587-019-0201-4. View

4.
Duan Z, Andronescu M, Schutz K, Mcilwain S, Kim Y, Lee C . A three-dimensional model of the yeast genome. Nature. 2010; 465(7296):363-7. PMC: 2874121. DOI: 10.1038/nature08973. View

5.
Spriggs A, Boddington M, Clarke C . Chromosomes of human cancer cells. Br Med J. 1962; 2(5317):1431-5. PMC: 1926782. DOI: 10.1136/bmj.2.5317.1431. View